BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3370078)

  • 1. Randomized placebo-controlled double-blind cross-over study on antihypoxidotic effects of piracetam using psychophysiological measures in healthy volunteers.
    Schaffler K; Klausnitzer W
    Arzneimittelforschung; 1988 Feb; 38(2):288-91. PubMed ID: 3370078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.
    Saletu B; Hitzenberger G; Grünberger J; Anderer P; Zyhlarz G; Linzmayer L; Rameis H
    Int J Clin Pharmacol Ther; 1995 May; 33(5):249-62. PubMed ID: 7655763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of piracetam on volunteers in a low-pressure tank.
    Demay F; Bande J
    J Int Med Res; 1980; 8(1):90-4. PubMed ID: 7358211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of two dosages of orally administered midazolam on psychomotor performance in healthy volunteers.
    Schaffler K; Klausnitzer W
    Arzneimittelforschung; 1989 Mar; 39(3):395-8. PubMed ID: 2757665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose study on buspirone versus diazepam in volunteers. Monitoring psychomotor performance via oculomotor, choice reaction and electromyographic parameters.
    Schaffler K; Klausnitzer W
    Arzneimittelforschung; 1988 Feb; 38(2):282-7. PubMed ID: 3370077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypoxia model in human psychopharmacology: neurophysiological and psychometric studies with aniracetam i.v.
    Saletu B; Grünberger J
    Hum Neurobiol; 1984; 3(3):171-81. PubMed ID: 6434496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacodynamic bioequivalence of piracetam in hypoxic hypoxia].
    Schaffler K
    Arzneimittelforschung; 1986 May; 36(5):845-9. PubMed ID: 3730020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled study on acute and subchronic effects of buspirone vs bromazepam utilizing psychomotor and cognitive assessments in healthy volunteers.
    Schaffler K; Klausnitzer W
    Pharmacopsychiatry; 1989 Jan; 22(1):26-33. PubMed ID: 2565582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High versus low-dose piracetam in alcohol organic mental disorder: a placebo controlled study.
    Barnas C; Miller C; Ehrmann H; Schett P; Günther V; Fleischhacker WW
    Psychopharmacology (Berl); 1990; 100(3):361-5. PubMed ID: 2179979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double blind study of the hypoxia protective effect of a standardized Ginkgo biloba preparation after repeated administration in healthy subjects].
    Schaffler K; Reeh PW
    Arzneimittelforschung; 1985; 35(8):1283-6. PubMed ID: 3907639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies.
    Saletu B; Grünberger J; Anderer R
    Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):510-24. PubMed ID: 2086492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piracetam in alcoholic psychoses: a double-blind, crossover, placebo controlled study.
    Skondia V; Kabes J
    J Int Med Res; 1985; 13(3):185-7. PubMed ID: 3891457
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of piracetam upon visual event-related potentials in dyslexic children.
    Conners CK; Reader M; Reiss A; Caldwell J; Caldwell L; Adesman A; Mayer L; Berg M; Clymer R; Erwin R
    Psychophysiology; 1987 Sep; 24(5):513-21. PubMed ID: 3685231
    [No Abstract]   [Full Text] [Related]  

  • 15. [Piracetam in the treatment of soft tissue rheumatism].
    Glas-Schöttl R
    Fortschr Med; 1989 Apr; 107(13):298-302. PubMed ID: 2656442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies.
    Saletu B; Schulz H; Herrmann WM; Anderer P; Shrotriya RC; Vanbrabant E
    Pharmacopsychiatry; 1994 Sep; 27(5):189-97. PubMed ID: 7838889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piracetam in chronic brain failure.
    Lloyd-Evans S; Brocklehurst JC; Palmer MK
    Curr Med Res Opin; 1979; 6(5):351-7. PubMed ID: 540525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychophysiological research in psychiatry and neuropsychopharmacology. II. The investigation of antihypoxidotic/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS).
    Saletu B; Semlitsch HV; Anderer P; Resch F; Presslich O; Schuster P
    Methods Find Exp Clin Pharmacol; 1989 Jan; 11(1):43-55. PubMed ID: 2716439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Psychopharmacol Bull; 1978 Jan; 14(1):23-5. PubMed ID: 343146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.